06.01.2021 • News

UK Regulator Investigates Tronox TiZir Buy

The UK’s Competition and Markets Authority (CMA) intends to open a Phase 2 investigation into Tronox’s proposed purchase of the TiZir titanium and iron business from French multinational mining and metallurgy group Eramet.

However, Tronox said that as a standard part of the process, the company may offer remedies to the CMA before it reaches a final decision on whether to begin the investigation. 

Under the terms of the takeover announced in May 2020, Tronox agreed to pay approximately $300 million for the TiZir business, which upgrades ilmenite to high-grade titanium slag and high-purity pig iron. The facility in Tyssedal, Norway, has annual capacities of 230,000 t/y of titanium slag and 90,000 t/y pig iron. The US pigment producer said the “highly strategic” acquisition would lower the cost of obtaining feedstock for its titanium operations.

While the proposed takeover did not require notification in the UK, or meet premerger reporting thresholds in the US, regulators in both countries launched investigations. A decision from the US Federal Trade Commission is still awaited.

Author: Elaine Burridge, Freelance Journalist

The UK’s Competition and Markets Authority is to open a Phase 2 investigation...
The UK’s Competition and Markets Authority is to open a Phase 2 investigation into Tronox’s proposed purchase of the TiZir titanium and iron business from French mining and metallurgy group Eramet. However, Tronox may offer remedies to the CMA before it reaches a final decision. (c) Tronox

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
19.05.2025 • NewsChemie

OQ Chemicals firmiert künftig wieder als Oxea

Der bis Mai 2020 unter dem Namen Oxea bekannte Hersteller von Oxo-Zwischenprodukten und Oxo-Derivaten, der zwischenzeitlich zum Omanischen Energieunternehmen OQ gehörte und unter dem Namen OQ Chemicals firmierte, kehrt zu seinem alten Namen und seinen Wurzeln zurück.

Photo
08.08.2025 • News

Carbios und Indorama kooperieren bei rPET

Carbios wird recycelte Monomere bereitstellen, die von Indorama Ventures zu Filamenten für die Verstärkung von Reifen des Herstellers Michelin verarbeitet werden.